Showing results (281-290 of 286) with videos related to
Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 286 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2024
YAP Regulates HER3 Signaling-Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant CancersYuki Katayama, Tadaaki Yamada, Keiko Tanimura, et al.NPJ Precision Oncology|April 2, 2026
AXL-SHC1 signaling axis mediates adaptive resistance to HER2-targeted tyrosine kinase inhibitors in HER2-aberrant lung and gastric cancersMasaki Ishida, Tadaaki Yamada, Yuki Katayama, et al.Cancer Science|September 28, 2022
High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinibAkihiro Yoshimura, Tadaaki Yamada, Masakuni Serizawa, et al.NPJ Precision Oncology|May 28, 2024
Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosisTej D Azad, Shigeki Nanjo, Michael C Jin, et al.The Journal of Clinical Investigation|May 17, 2022
Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancerShigeki Nanjo, Wei Wu, Niki Karachaliou, et al.Oncotarget|May 4, 2017
A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancerSheila X Soh, Fahad J Siddiqui, John C Allen, et al.Pageof 29